Chronic administration of adrenomedullin attenuates hypoxic pulmonary vascular structural remodeling and inhibits proadrenomedullin N-terminal 20-peptide production in rats

Peptides

Volumn 28, Issue 4, 2007, Pages 910-919

  Qi, Jian Guang ^a   Ding, Ya Guang ^a   Tang, Chao Shu ^a,b   Du, Jun Bao ^a,b  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Adrenomedullin; Artery; Hypoxia; Proadrenomedullin N terminal 20 peptide; Pulmonary hypertension

Indexed keywords

ADRENOMEDULLIN; CELL NUCLEUS ANTIGEN; MESSENGER RNA; PROADRENOMEDULLIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG INHIBITION; HYPOXIA; LUNG ARTERY PRESSURE; LUNG BLOOD VESSEL; LUNG HEMODYNAMICS; MALE; NONHUMAN; OSMOTIC PUMP; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PULMONARY ARTERY; RAT; SMOOTH MUSCLE FIBER; ULTRASTRUCTURE;

ADRENOMEDULLIN; ANIMALS; ANOXIA; BLOOD PRESSURE; BLOOD VESSELS; BRONCHODILATOR AGENTS; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MICROSCOPY, ELECTRON; PROLIFERATING CELL NUCLEAR ANTIGEN; PULMONARY ARTERY; RADIOIMMUNOASSAY; RATS; RATS, WISTAR;

RATTUS;

EID: 33847390312     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2006.12.008     Document Type: Article

References (24)

1. Barth P.J., Kimpel C., Roy S., and Wagner C. An improved mathematical approach for the assessment of the medial thickness of pulmonary arteries. Pathol Res Pract 189 (1993) 567-576
2. Beltowski J., and Jamroz A. Adrenomedullin-what do we know 10 years since its discovery?. Pol J Pharmacol 56 (2004) 5-27
3. EtoT. A review of the biological properties and clinical implications of adrenomedudullin and proadrenomedullin N-terminal 20 peptide (PAMP), hypotensive and vasodilating peptides. Peptides 2001;22:1693-711.
4. Hislop A.A., Springall D.R., Buttery L.D.K., Pollock J.S., and Haworth S.G. Abundance of endothelial nitric oxide synthase in newborn intrapulmonary arteries. Arch Dis Child Fetal Neonatal Ed 73 1 (1995) F17-F21
5. Ichiki Y., Kitamura K., Kangawa K., Kawamoto M., Matsuo H., and Eto T. Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma. FEBS Lett 338 (1994) 6-10
6. Jeffery T.K., and Morrel N.W. Molecular and cellular basis of pulmonary vascular remodeling in pulmonary hypertension. Prog Cardiovas Dis 45 3 (2002) 173-202
7. Kakishita M., Nishikimi T., Okano Y., Satoh T., Kyotani S., Nagaya N., et al. Increased plasma levels of adrenomedullin in patients with pulmonary hypertension. Clin Sci (London) 96 (1999) 33-39
8. Kano H., Kohno M., Yasunari K., Yokokawa K., Horio T., Ikeda M., et al. Adrenomedullin as a novel antiproliferative factor of vascular smooth muscle cells. J Hypertens 14 (1996) 209-213
9. Kitamura K., Kangawa K., Kawamoto M., Ichiki Y., Nakamura S., Matsuo H., et al. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 192 (1993) 553-560
10. Kitamura K., Sakata J., Kangawa K., Kojima M., Matsuo H., and Eto T. Cloning and characterization of cDNA encoding a precursor for human adrenomodullin. Biochem Biophys Res Commun 194 (1993) 720-725
11. Matsui H., Shimosawa T., Itakura K., Xing G.Q., Ando K., and Fujita T. Adrenomedullin can protect against pulmonary vascular remodeling induced by hypoxia. Circulation 109 (2004) 2246-2251
12. 2-terminal 20 peptide (PAMP) and adrenomedullin bind to teratocarcinoma cells. Peptides 21 (2000) 101-107
13. Nakanishi K., Osada H., Uenoyama M., Kanazawa F., Ohrui N., Masaki Y., et al. Expressions of adrenomedullin mRNA and protein in rats with hypobaric hypoxia-induced pulmonary hypertension. Am J Physiol Heart Circ Physiol 286 (2004) H2159-H2168
14. Nagaya N., Nishikimi T., Uematsu M., Satoh T., Oya H., Kyotani S., et al. Hemodynamic and hormonal effects of adrenomedullin in patients with pulmonary hypertension. Heart 84 (2000) 653-658
15. Nagaya N., Kyotani S., Uematsu M., Ueno K., Oya H., Nakanishi N., et al. Effects of adrenomedullin inhalation on hemodynamics and exercise capacity in patients with idiopathic pulmonary arterial hypertension. Circulation 109 (2004) 351-356
16. Nagaya N., Okumura H., Uematsu M., Shimizu W., Ono F., Shirai M., et al. Repeated inhalation of adrenomedullin ameliorates pulmonary hypertension and survival in monocrotaline rats. Am J Physiol Heart Circ Physiol 285 5 (2003) H2125-H2131
17. Owji A.A., Smith D.M., Coppock H.A., Morgan D.G., Bhogal R., Ghatei M.A., et al. An abundant and specific binding site for the novel vasodilator adrenomedullin in the rat. Endocrinology 136 (1995) 2127-2134
18. Qi Y.F., Bu D.F., Niu D.D., Shi Y.R., Wang S.H., Pang Y.Z., et al. Effects of different peptide fragments derived from proadrenomedullin on gene expression of adrenomedullin gene. Peptides 23 (2002) 1141-1147
19. Shi Y., Du J.B., Gong L.M., Zeng C.M., Tang X.Y., and Tang C.S. The regulating effect of heme oxygenase/carbon monoxide on hypoxic pulmonary vascular structural remodeling. Biochem Biophys Res Commun 306 (2003) 523-529
20. Tang J., Tang C.S., Chen G.H., Zhou A.R., Wang X., Ma D.L., et al. Intramolecular regulation of cardiovascular bioactive peptides. Sci Technol Rev 10 (1996) 3-10
21. Wei B., Du J.B., Li J., Qi J.G., and Tang C.S. l-Arginine impacts pulmonary vascular structure in rats with an aortocaval shunt. J Surg Res 108 (2002) 20-31
22. Yamaguchi M., Hayashi Y., Hirose F., Matsuoka S., Moriuchi T., Shiroishi T., et al. Molecular cloning and structural analysis of mouse gene and pseudogenes for proliferating cell nuclear antigen. Nucl Acids Res 19 (1991) 2403-2410
23. Yoshihara F., Nishikimi T., Horio T., Yutani C., Nagaya N., Matsuo H., et al. Ventricular adrenomedullin concentration is a sensitive biochemical marker for volume and pressure overload in rats. Am J Physiol Heart Circ Physiol 278 (2000) H633-H642
24. Yoshihara F., Nishikimi T., Horio T., Yutani C., Takishita S., Matsuo H., et al. Chronic infusion of adrenomedullin reduces pulmonary hypertension and lessens right ventricular hypertrophy in rats administered monocrotaline. Eur J Pharmocol 355 (1998) 33-39